TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Key Financials
Gross Profit
$8.9B
↑ 10.8%
Net Income
$1.4B
↑ 186.0%
Operating Income
$2.2B
↑ 811.9%
Revenue
$1.5B
N/A
EPS (Diluted)
$1.21
↑ 183.4%
Total Assets
$40.7B
↑ 3.6%
Cash & Equivalents
$3.6B
↑ 7.8%
Total Liabilities
$32.8B
↓ 2.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 3/31/2026 | View on SEC |
| ARS | 3/31/2026 | View on SEC |
| DEF 14A | 3/31/2026 | View on SEC |
| 4 | 3/19/2026 | View on SEC |
| 144 | 3/17/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
| 4 | 3/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TEVA |
| Company Name | TEVA PHARMACEUTICAL INDUSTRIES LTD |
| CIK | 818686 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 972 (3) 914-8213 |